By Mitul Agarwal, B.Pharm, MBA. Published October 2026.
A CRO (contract research organisation) runs research and studies for you, such as clinical trials and bioequivalence studies, and hands back data. A CMO (contract manufacturing organisation) makes your product using a process you already own. A CDMO (contract development and manufacturing organisation) does both halves of the job: it can take a molecule or a product idea through formulation, scale-up and stability testing all the way to commercial batches.
The labels are useful, but they are also used loosely. Many companies now describe themselves with all three sets of initials, and some have invented new ones. So the sensible question to ask a potential partner is not what it calls itself, but what it will actually do for your product, and to which standard.
The full forms, and a few cousins
CRO stands for Contract Research Organisation. CMO stands for Contract Manufacturing Organisation, although in a company's leadership team the same three letters usually mean Chief Medical Officer (or, outside pharma, Chief Marketing Officer). CDMO stands for Contract Development and Manufacturing Organisation.
Two more turn up often. A CRDMO, a Contract Research, Development and Manufacturing Organisation, adds discovery and research chemistry to the CDMO model; the term is popular with several Indian and Chinese companies that want to cover a product's whole life, from the first molecule to commercial supply. A CSO, or Contract Sales Organisation, is a different animal altogether: it provides sales teams rather than science or plants.
How they compare
| CRO | CDMO | CMO | |
|---|---|---|---|
| Main job | Research and studies | Develops the product, then makes it | Makes the product to your process |
| Typical work | Clinical trials, bioequivalence (BA/BE) studies, preclinical tests, bioanalysis, data management, regulatory writing | Formulation, analytical methods, scale-up, stability studies, tech transfer, clinical and commercial batches, CMC documents for the dossier | Commercial manufacturing, packing, release testing |
| You bring | A protocol, or a question to answer | A molecule, a target product or an existing product to improve | A validated process and specifications |
| Main quality standard | GCP (ICH E6) for trials; GLP for non-clinical labs | GMP, plus development data that meets ICH guidelines | GMP |
| What you get | Study reports and data | A product, its process and the technical documents | Released batches |
| Key contracts | Service agreement and study protocol | Development, supply and quality agreements | Supply and quality agreements |
Which one do you need?
The answer depends on where your product is today.
If you have a new molecule and need human data, a CRO runs the trials while a CDMO makes the clinical supplies.
If you want a generic for your market but have no dossier, a CDMO can develop the formulation and run the stability studies, and a CRO runs the bioequivalence study that most regulators require. Some CDMOs arrange the BE study through a partner CRO, which saves you managing two relationships. Another route is to license a dossier that already exists; our guide to out-licensing a generic dossier explains how those deals work.
If you already have a registered product and simply need more capacity or a second source, a CMO is enough. Just plan for the tech transfer and the registration variation that comes with a new site.
And if all you want is to sell under your own brand, white label may be quicker than any of these, because the product has already been developed and registered. Our white-label manufacturing service covers that route.
One product, three partners
It helps to see how the roles fit together on a real project. Imagine a company launching a generic tablet in several emerging markets.
The work starts with a CDMO, which sources the API, develops a formulation that matches the reference product, validates its test methods and makes pilot batches. Those batches go on stability studies at the climatic conditions of the target markets. Meanwhile a CRO compares the new tablet with the reference product in healthy volunteers and writes up the bioequivalence study. The CDMO then prepares the quality (CMC) sections of the dossier, the CRO supplies its study report, and the company files with each regulator. Once the product is approved, the same site may make commercial batches, or the process may move to a CMO with more capacity or a lower cost base.
One company can sometimes play all three roles. Even then, the work and the standards behind each step are different, so check each one on its own merits.
How each one charges
CROs usually price per study, with a budget broken down by activity: sites, patients or volunteers, monitoring, laboratory work and the final report. Longer programmes are sometimes run by a dedicated team billed per person.
CDMOs generally price development as work packages or milestones, then quote commercial supply per batch or per unit. Some will accept lower development fees in exchange for a long-term supply contract.
CMOs quote per batch or per unit, often with a minimum order and a one-off technology-transfer fee at the start.
Who owns what
This is the question buyers tend to forget until it matters.
With a CRO, the sponsor normally owns the study data and the reports. With a CMO, you own the product and the process, while the manufacturer keeps its plant know-how and equipment. The CDMO is where ownership needs most care. Some CDMOs develop for a fee and hand everything over. Others fund development themselves, keep the dossier and license it out. Neither model is wrong, but the development agreement has to say clearly who holds the dossier, who may file it in which countries and what happens if you later move production elsewhere.
What to check before you sign
Start with approvals that match your market. A WHO-GMP site may be perfectly acceptable for many emerging markets and still not suit the EU or the US, and a site's inspection history tells you more than its certificate. Our article on which certifications actually matter goes into this.
Then look for real experience with your dosage form: products of the same type the site already makes, and the batch sizes it runs. For a CRO, ask about its regulatory registrations for the type of study and whether your target regulator has accepted its past studies.
Finally, insist on a quality agreement that says who releases batches, who handles complaints and recalls, and how changes will be notified, and agree up front which documents you will receive. From a CDMO, that means the CMC sections of the dossier in CTD or ACTD format; our guide to CTD and ACTD explains the difference.
Where to go next
Our CDMO and contract manufacturing guide hub brings together every PharmaTradz guide on choosing and working with manufacturers, including 50+ leading CDMO companies in India and the top global CDMOs. If you already know your dosage form, our contract manufacturing pages for tablets, hard capsules, softgels and oral liquids are a good place to start. For the regulatory vocabulary, see drug substance versus drug product.
Tell us what you need developed or made, and for which market, and send us an RFQ. If you are a manufacturer or CDMO yourself, you can list your capabilities to reach buyers.
Frequently Asked Questions(FAQs)
What is the full form of CDMO?
CDMO stands for Contract Development and Manufacturing Organisation: a company that develops a medicine's formulation and manufacturing process for a client, and then makes it.
What is the difference between a CDMO and a CMO?
A CMO manufactures to a process the client already has. A CDMO also does the development work behind it: formulation, scale-up, stability studies and the technical documents a registration needs.
What is the difference between a CRO and a CDMO?
A CRO runs research and studies, such as clinical trials and bioequivalence studies, and delivers data. A CDMO develops and makes the product itself. Most new products need both.
What does CMO mean in pharma?
In outsourcing, it means Contract Manufacturing Organisation. In a company's leadership team, the same letters usually mean Chief Medical Officer.
What is a CRDMO?
A Contract Research, Development and Manufacturing Organisation. It adds discovery and research chemistry to development and manufacturing, so a client can stay with one partner from early research through to commercial supply.
Who owns the dossier when a CDMO develops a product?
Whoever the development agreement says. Some CDMOs develop for a fee and transfer everything; others fund the work, keep the dossier and license it. Agree this in writing before development starts.
